Pharmaceutical Pipeline

Showing 483 articles
World

Whistleblower Complaint Against Intelligence Chief Gabbard Stalled for Months, Sparking Bipartisan Scrutiny

A complaint alleging misconduct by Director of National Intelligence Tulsi Gabbard has been withheld from congressional oversight committees for eight months, her office citing an extended legal review. The delay, disputed by the complainant's attorney, raises questions about transparency and adherence to whistleblower protection laws within the nation's top intelligence office.

Business

Plug Power Pushes Shareholders for Crucial Vote on Share Authorization, Citing Growth and Reverse Split Risks

In a detailed business update, Plug Power's CEO Andy Marsh made a direct appeal to shareholders to approve an increase in authorized shares, framing it as essential for meeting financial obligations and funding future growth. He warned that failure to pass the proposal would force the company to pursue a reverse stock split—a move he believes historically damages shareholder value.